InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
9
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Woody Joseph Fralin, Chief Executive Officer. Insider active across 2 companies, notably Avanos Medical, INC.. In total, 23 reports have been published. Breakdown: 9 buys · 0 sell. Total volume traded: €108k. History available since 17 March 2021. The latest transaction was filed on 3 June 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Woody Joseph Fralin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
5,200 sharesCommon StockSEC:0001193125-26-266397:0
Canonical exit: 7 Sept 2026 (T+90)
5,000 sharesCommon StockSEC:0001193125-26-263968:1
Canonical exit: 7 Sept 2026 (T+90)
5,000 sharesCommon StockSEC:0001193125-26-263968:0
Canonical exit: 7 Sept 2026 (T+90)
5,000 shares@ US$4.09990.0094% mcap16.3% of flowCommon StockSEC:0001709989-26-000011:0
Canonical exit: 1 Sept 2026 (T+90)
5,000 shares@ US$4.08990.0094% mcap16.2% of flowCommon StockSEC:0001709989-26-000011:1
Canonical exit: 1 Sept 2026 (T+90)
40,547 sharesCommon StockSEC:0001709989-26-000008:0
22,214 sharesCommon StockSEC:0001709989-26-000008:1
5,000 shares@ US$4.260.0098% mcap25.1% of flowCommon StockSEC:0001709989-26-000006:1
Canonical exit: 30 Aug 2026 (T+90)
5,000 shares@ US$4.340.0099% mcap25.5% of flowCommon StockSEC:0001709989-26-000006:0
Canonical exit: 30 Aug 2026 (T+90)
5,000 shares@ US$4.18020.0096% mcap24.6% of flowCommon StockSEC:0001709989-26-000006:2
Canonical exit: 31 Aug 2026 (T+90)
5,000 shares@ US$4.20710.0096% mcap24.8% of flowCommon StockSEC:0001709989-26-000006:3
Canonical exit: 31 Aug 2026 (T+90)
11,827 shares@ US$15.301.8% of flowCommon StockSEC:0001606498-25-000040:0
32,158 shares0Common StockSEC:0001606498-25-000033:0
15,821 shares0Common StockSEC:0001606498-24-000049:0
7,095 shares@ US$19.091.3% of flowCommon StockSEC:0001606498-24-000049:1
26,670 shares@ US$19.094.9% of flowCommon StockSEC:0001606498-24-000049:2
137,147 shares@ US$19.1425.4% of flowCommon StockSEC:0001606498-24-000036:0
8,431 shares@ US$18.761.5% of flowCommon StockSEC:0001606498-24-000024:0
57,256 shares@ US$23.9713.1% of flowCommon StockSEC:0001606498-23-000044:0
8,314 shares@ US$29.622.4% of flowCommon StockSEC:0001606498-23-000024:1
86,547 shares0Common StockSEC:0001606498-23-000024:0
80,933 shares0Common StockSEC:0001606498-22-000031:0
59,477 shares@ US$47.2933.0% of flowCommon StockSEC:0001606498-21-000049:0
23 of 23 declarations
About Woody Joseph Fralin
Woody Joseph Fralin is Directeur Général and appears in 23 filings. His 23 sampled filings cover the period from 2021-09-10 to 2026-06-10, with EUR 108387 of buys and EUR 0 of sells, and the most common transaction nature is Acquisition. He is associated with Avanos Medical, INC. and AVITA Medical, Inc., where he is Director.
